4//SEC Filing
Shanmugam Muthusamy 4
Accession 0001870913-24-000016
CIK 0001023024other
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 6:26 PM ET
Size
8.8 KB
Accession
0001870913-24-000016
Insider Transaction Report
Form 4
Shanmugam Muthusamy
DirectorHEAD OF R&D, COO-NOVITIUM OPS
Transactions
- Sale
Common Stock
2024-04-19$65.17/sh−16,809$1,095,443→ 782,620 total(indirect: By LLC) - Sale
Common Stock
2024-04-18$64.98/sh−10,423$677,287→ 799,429 total(indirect: By LLC)
Holdings
- 68,652
Common Stock
- 5,000(indirect: By LLC)
Common Stock
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023.
- [F2]The shares were sold in multiple trades at prices ranging from $64.43 to $65.89. The price reported above reflects the weighted average sales price.
- [F3]The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- [F4]The shares were sold in multiple trades at prices ranging from $64.20 to $65.79. The price reported above reflects the weighted average sales price.
- [F5]The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001870913
Filing Metadata
- Form type
- 4
- Filed
- Apr 21, 8:00 PM ET
- Accepted
- Apr 22, 6:26 PM ET
- Size
- 8.8 KB